Search research articles
Contact Us
Filters
Showing results (251-260 of 386) with videos related to
Page
of 39
Sort By:
The American Journal of Surgical Pathology
|
September 2, 2011
Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas
Luciana Schultz, Alcides Chaux, Roula Albadine, et al.
Science Translational Medicine
|
January 9, 2015
Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study
Michael T Schweizer, Emmanuel S Antonarakis, Hao Wang, et al.
The Prostate
|
January 29, 2026
Phase II Randomized Study of MK-2206 and Bicalutamide in Prostate Cancer Patients With Rising PSA After Primary Therapy (ECOG-ACRIN E2809)
Anna C Ferrari, Yu-Hui Chen, Ronald Rodríguez, et al.
JAMA Oncology
|
September 17, 2020
Willingness to Discuss Clinical Trials Among Black vs White Men With Prostate Cancer
Nicole Senft, Lauren M Hamel, Mark A Manning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Phase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with a unique pharmacology and toxicity profile
Antonio C Wolff, Ross C Donehower, M Katherine Carducci, et al.
Clinical Genitourinary Cancer
|
May 24, 2016
Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma
Daniel Keizman, Maya Ish-Shalom, Avishay Sella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 2018
Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer
Alicia K Morgans, Yu-Hui Chen, Christopher J Sweeney, et al.
Frontiers in Medicine
|
June 20, 2019
Factors Affecting Combination Trial Success (FACTS): Investigator Survey Results on Early-Phase Combination Trials
Channing J Paller, Erich P Huang, Thomas Luechtefeld, et al.
Prostate Cancer and Prostatic Diseases
|
June 13, 2012
A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer
C J Paller, X Ye, P J Wozniak, et al.
Marine Pollution Bulletin
|
September 23, 2019
Enteric viruses, somatic coliphages and Vibrio species in marine bathing and non-bathing waters in Italy
L Bonadonna, R Briancesco, E Suffredini, et al.
Page
of 39
Search research articles
Search
Showing results (251-260 of 386) with videos related to
Sort By:
Page
of 39
The American Journal of Surgical Pathology
|
September 2, 2011
Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas
Luciana Schultz, Alcides Chaux, Roula Albadine, et al.
Science Translational Medicine
|
January 9, 2015
Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study
Michael T Schweizer, Emmanuel S Antonarakis, Hao Wang, et al.
The Prostate
|
January 29, 2026
Phase II Randomized Study of MK-2206 and Bicalutamide in Prostate Cancer Patients With Rising PSA After Primary Therapy (ECOG-ACRIN E2809)
Anna C Ferrari, Yu-Hui Chen, Ronald Rodríguez, et al.
JAMA Oncology
|
September 17, 2020
Willingness to Discuss Clinical Trials Among Black vs White Men With Prostate Cancer
Nicole Senft, Lauren M Hamel, Mark A Manning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Phase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with a unique pharmacology and toxicity profile
Antonio C Wolff, Ross C Donehower, M Katherine Carducci, et al.
Clinical Genitourinary Cancer
|
May 24, 2016
Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma
Daniel Keizman, Maya Ish-Shalom, Avishay Sella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 2018
Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer
Alicia K Morgans, Yu-Hui Chen, Christopher J Sweeney, et al.
Frontiers in Medicine
|
June 20, 2019
Factors Affecting Combination Trial Success (FACTS): Investigator Survey Results on Early-Phase Combination Trials
Channing J Paller, Erich P Huang, Thomas Luechtefeld, et al.
Prostate Cancer and Prostatic Diseases
|
June 13, 2012
A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer
C J Paller, X Ye, P J Wozniak, et al.
Marine Pollution Bulletin
|
September 23, 2019
Enteric viruses, somatic coliphages and Vibrio species in marine bathing and non-bathing waters in Italy
L Bonadonna, R Briancesco, E Suffredini, et al.
Page
of 39